Enhanced susceptibility of ovaries from obese mice to 7,12-dimethylbenz[a]anthracene-induced DNA damage by Ganesan, Shanthi et al.
Animal Science Publications Animal Science
12-1-2014
Enhanced susceptibility of ovaries from obese mice
to 7,12-dimethylbenz[a]anthracene-induced DNA
damage
Shanthi Ganesan
Iowa State University, shanthig@iastate.edu
Jackson Nteeba
Iowa State University
Aileen F. Keating
Iowa State University, akeating@iastate.edu
Follow this and additional works at: https://lib.dr.iastate.edu/ans_pubs
Part of the Animal Experimentation and Research Commons, Animal Sciences Commons,
Cellular and Molecular Physiology Commons, and the Genetics Commons
The complete bibliographic information for this item can be found at https://lib.dr.iastate.edu/
ans_pubs/472. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Animal Science at Iowa State University Digital Repository. It has been accepted for
inclusion in Animal Science Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please
contact digirep@iastate.edu.
Enhanced susceptibility of ovaries from obese mice to
7,12-dimethylbenz[a]anthracene-induced DNA damage
Abstract
7,12-dimethylbenz[a]anthracene (DMBA) depletes ovarian follicles and induces DNA damage in extra-
ovarian tissues, thus, we investigated ovarian DMBA-induced DNA damage. Additionally, since obesity is
associated with increased offspring birth defect incidence, we hypothesized that a DMBA-induced DNA
damage response (DDR) is compromised in ovaries from obese females. Wild type (lean) non agouti (a/a)
and KK.Cg-Ay/J heterozygote (obese) mice were dosed with sesame oil or DMBA (1mg/kg; intraperitoneal
injection) at 18 wks of age, for 14 days. Total ovarian RNA and protein were isolated and abundance of Ataxia
telangiectasia mutated (Atm), X-ray repair complementing defective repair in chinese hamster cells 6 (Xrcc6),
Breast cancer type 1 (Brca1), Rad 51 homolog (Rad51), Poly [ADP-ribose] polymerase 1 (Parp1) and
Protein kinase, DNA-activated, catalytic polypeptide (Prkdc) were quantified by RT-PCR or Western blot.
Phosphorylated histone H2AX (γH2AX) level was determined by Western blotting. Obesity decreased (P <
0.05) basal protein abundance of PRKDC and BRCA1 proteins but increased (P < 0.05) γH2AX and PARP1
proteins. Ovarian ATM, XRCC6, PRKDC, RAD51 and PARP1 proteins were increased (P < 0.05) by DMBA
exposure in lean mice. A blunted DMBA-induced increase (P < 0.05) in XRCC6, PRKDC, RAD51 and
BRCA1 was observed in ovaries from obese mice, relative to lean counterparts. Taken together, DMBA
exposure induced γH2AX as well as the ovarian DDR, supporting that DMBA causes ovarian DNA damage.
Additionally, ovarian DDR was partially attenuated in obese females raising concern that obesity may be an
additive factor during chemical-induced ovotoxicity.
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decreased (P < 0.05) basal protein abundance of PRKDC and BRCA1 proteins but increased (P < 
0.05) γH2AX and PARP1 proteins. Ovarian ATM, XRCC6, PRKDC, RAD51 and PARP1 
proteins were increased (P < 0.05) by DMBA exposure in lean mice. A blunted DMBA-induced 
increase (P < 0.05) in XRCC6, PRKDC, RAD51 and BRCA1 was observed in ovaries from obese 
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the ovarian DDR, supporting that DMBA causes ovarian DNA damage. Additionally, ovarian 
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Introduction
7,12-dimethylbenz[a]anthracene (DMBA) is a polycyclic aromatic hydrocarbon which 
destroys all follicle types leading to ovarian failure in mice and rats (Mattison and 
Schulman, 1980) and is one component liberated through cigarette smoke and car exhaust 
fumes (Gelboin, 1980). It is recognized that female smokers experience ovarian senescence 
at an earlier age than their non-smoking counterparts (Jick and Porter, 1977), and low level 
DMBA exposure caused follicle depletion in neonatal culture rat ovaries, raising concern 
that ovotoxicity can be induced at levels which may be representative of passive DMBA 
exposure (Madden et al., 2014).
DMBA requires the action of ovarian enzymes cytochromes p450 (Cyp) isoforms 1A1 and 
1B1 (Shimada et al., 2003) and microsomal epoxide hydrolase (mEH) (Rajapaksa et al., 
2007; Igawaet al., 2009; Madden et al., 2014) for biotransformation to the ovotoxic 
metabolite, DMBA 3,4-diol, 1,2-epoxide, which is both carcinogenic and has the potential to 
form DNA adducts (Miyataet al., 1999). DMBA exposure also induces the DNA damage 
response (DDR) in cultured neonatal rat ovaries, indicating that DNA damage is a potential 
mechanism by which DMBA induces its ovotoxic effects (Ganesan et al., 2013).
Double-strand breaks (DSBs) in DNA are cytotoxic lesions, generated by ionizing radiation 
and man-made chemicals (van Gent et al., 2001). DSB's can be sensed by a PI3K family 
member Ataxia telangiectasia mutated (ATM) protein (Norbury and Hickson, 2001; Yang et 
al., 2003; Giunta et al., 2010). ATM phosphorylates histone H2AX (γH2AX) which leads, 
within seconds, to recruitment of DNA repair molecules to the site of DSBs (Sedelnikova et 
al., 2002; Svetlovaet al., 2010), thus γH2AX has become a gold standard marker for 
localizing DSBs. DNA DSB's pose a serious threat to both cell viability and genome 
stability if left unrepaired or repaired incorrectly, and could potentially lead to permanent 
damage with resulting negative consequences for gamete health (Petrillo et al., 2011; 
Summers et al., 2011). Two major pathways can repair DNA DSB's: Non-Homologous End 
Joining (NHEJ) (Chiruvella et al., 2012) and Homologous Recombination (HR) (Scully et 
al., 1997). Key signaling molecules involved in NHEJ repair include the X-ray repair 
complementing defective repair in Chinese hamster cells 6 and 5 (XRCC6 and XRCC5) 
heterodimer which recognizes and binds to the DSB, recruiting protein kinase DNA-
activated, catalytic polypeptide (PRKDC) to the DSB ends (Calsou et al., 2003; Dobbs et 
al., 2010; Chiruvella et al., 2012). During HR, breast cancer type 1 (BRCA1) can be 
phosphorylated by ATM and co-localizes with RAD51 recombinase (RAD51) at the site of 
DNA damage to induce DSB repair (Scully et al., 1997).
Approximately 65% of women in the United States are overweight or obese (Flegal et al., 
2010) and the associated reproductive complications include menstrual cycle disturbances, 
ovulatory dysfunction, infertility, decreased conception, early pregnancy loss and congenital 
abnormalities in offspring (Cardozo et al., 2012; Sauber-Schatz et al., 2012). Obesity has 
been associated with altered insulin and insulin growth factor (IGF) signaling (Qatanani and 
Lazar, 2007), likely due to obese females being typically hyperinsulinemic with concomitant 
insulin resistance (Kashyap, 2007; Choi and Kim, 2010). Insulin serves as a regulator of 
hepatic enzymes involved in the metabolism of xenobiotics (Woodcroft and Novak, 1999), 
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mediated, at least partly, through activation of phosphatidylinositol-3 kinase (PI3K) and 
variety of downstream effectors including protein kinase B (Akt) (Niswender et al., 2003; 
Kim and Novak, 2007). Insulin increases mEH protein expression in primary cultured rat 
hepatocytes (Kim et al., 2003). Also, increased ovarian PI3K signaling and mEH have been 
demonstrated in mice fed a high fat diet until obese (Nteebaet al., 2013). The obese lethal 
yellow mouse was also found to have both higher basal levels of mEH and greater mEH 
induction in response to DMBA exposure (Nteeba et al., 2014). These data suggest that 
ovarian tissue from obese females could have potentially greater exposure to the ovotoxic 
metabolite of DMBA, due to higher levels of ovarian mEH, and thus greater DMBA 
bioactivation to a metabolite that interacts with DNA (Miyata et al., 1999). The objective of 
this study was therefore to investigate ovarian DMBA-induced DNA damage as evidenced 
by γH2AX appearance and induction of the DDR in both lean and obese mice.
Methods and Materials
Reagents
7,12-dimethylbenz[a]anthracene (DMBA; CAS # 57-97-6), sesame oil (CAS # 8008-74-0), 
2-β-mercaptoethanol, 30% acrylamide/0.8% bisacrylamide, ammonium persulphate, 
glycerol, N′N′N′N′-Tetramethylethylenediamine (TEMED), Tris base, Tris HCL, Sodium 
chloride, Tween-20 were purchased from Sigma-Aldrich Inc. (St Louis, MO). RNeasy Mini 
kit, QIA shredder kit, RNeasy Min Elute kit, and Quantitect TM SYBR Green PCR kit were 
purchased from Qiagen Inc (Valencia, CA). All primers were purchased from the Iowa State 
University DNA facility. All primary antibodies were purchased from Abcam (Cambridge, 
MA) with the exception of the BRCA1(C-20) primary antibody which was from Santa Cruz 
Biotechnology (Santa Cruz, CA). RNA later was obtained from Ambion Inc. (Austin, TX). 
Goat anti-mouse and anti-rabbit secondary antibodies were obtained from Santa Cruz 
Biotechnology (Santa Cruz, CA). Ponceau S was from Fisher Scientific. ECL plus chemical 
luminescence detection kit was obtained from GE Healthcare, Amersham 
(Buckinghamshire, UK).
Animals
Ovarian tissue was obtained as part of a larger study by our group (Nteeba et al., 2014). 
Briefly, four week old female wild type normal non-agouti (a/a; designated lean; n = 10) and 
agouti lethal yellow (KK.Cg-Ay/J; designated obese; n = 10) were purchased from Jackson 
laboratories (Bar Harbor, ME 002468). All animals were housed in cages under a 12 h light/
dark photoperiod with the temperature between 70-73°F and humidity approximately 
20-30%. The animals were provided with a standard diet (Teklad 2014 global 14% protein 
rodent maintenance diet) with ad libitum access to food and water until 18 weeks of age. All 
animal experimental procedures were approved by the Iowa State University Animal Care 
and Use Committee.
In vivo DMBA exposure
Both lean and obese mice were intraperitoneally (i.p.) dosed with sesame oil (SO) or DMBA 
(95%; 1mg/kg per day) for 14 days. This dose was chosen based on a report that it caused 
follicular loss in the ovary (Mattison and Thorgeirsson, 1979). Mice were euthanized 3 days 
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after the end of dosing in their pro-estrus phase. One ovary from each mouse was fixed in 
4% paraformaldehyde and one ovary was preserved at −80°C for RNA and protein isolation. 
This ovary was powdered and half used to isolate RNA and protein was isolated from the 
other half. As a note, one ovary from an obese DMBA-treated female could not be localized 
therefore the final number in this group was n = 4, with n = 5 for all other treatments. No 
difference in body weights due to DMBA exposure was observed although the lethal yellow 
mice had higher body weights (Nteeba et al., 2014). DMBA reduced ovarian weight and 
volume in both lean and obese mice, relative to vehicle treated mice, and ovarian weight and 
volume were lower in obese DMBA-treated relative to lean DMBA-treated mice (Nteeba et 
al., 2014).
RNA was isolated from all ovaries (n = 4-5) using an RNeasy Mini kit (Qiagen) and the 
concentration was determined using an ND-1000 Spectrophotometer (λ = 260/280nm; 
NanoDrop technologies, Inc., Wilmington, DE) (n = 3). Total RNA (200 ng) was reverse 
transcribed to cDNA utilizing the Superscript III One-Step RT-PCR (Qiagen). Three 
randomly chosen cDNA samples per treatment were diluted (1:20) in RNase-free water and 
amplified on an Eppendorf PCR Master cycler using Quantitect SYBR Green PCR kit 
(Qiagen). Primers for Atm, Brca1, Prkdc, Parp1, Rad51, Xrcc6 and Gapdh were designed by 
Primer 3 Input Version (0.4.0) and are listed in Table 1. The regular cycling program 
consisted of a 15 min hold at 95°C and 45 cycles of denaturing at 95°C for 15 s, annealing at 
58°C for 15 s, and extension at 72°C for 20 s at which point data were acquired. There was 
no difference in Gapdh mRNA expression between treatments, thus each sample was 
normalized to Gapdh before quantification. Quantification of fold-change in gene expression 
was performed using the 2−ΔΔCt method (Livak and Schmittgen, 2001; Pfaffl, 2001).
Protein isolation and Western blotting
Protein was isolated from whole ovaries (n = 4-5) that had been homogenized in tissue lysis 
buffer containing protease and phosphatase inhibitors as previously described (Thompson et 
al., 2005). Briefly, homogenized samples were placed on ice for 30 min, followed by two 
rounds of centrifugation at 10,000 rpm for 15 min. The protein concentration was measured 
using a standard BCA protocol. SDS-PAGE was used to separate three randomly chosen 
protein homogenates per treatment which were then transferred to a nitrocellulose 
membrane. Membranes were blocked for 1 h in 5 % milk in Tris-buffered saline containing 
tween 20, followed by incubation with one of: anti-rabbit PARP1 antibody (1:200), anti-
rabbit phosphorylated H2AX antibody (γH2AX; 1:100), anti-mouse ATM antibody (1:100), 
anti-mouse RAD51 antibody (1:500), anti-mouse XRCC6 antibody (1:100), anti-rabbit 
BRCA1 antibody (1:500), or anti-rabbit PRKDC antibody (1:100) for 36 h at 4°C. 
Following three washes in TTBS (1X), membranes were incubated with species-specific 
secondary antibodies (1:2000) for 1 h at room temperature. Membranes were washed 3X in 
TTBS and incubated in chemiluminescence detection substrate (ECL plus) for 5 min 
followed by X-ray film exposure. Densitometry of the appropriate bands was performed 
using ImageJ software (NCBI). Chemical exposures can impact traditional housekeeping 
protein abundance (our unpublished data), thus equal protein loading was confirmed by 
Ponceau S staining of total protein and protein level was normalized to Ponceau S 
densitometry values
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Statistical analysis
Sufficient animal numbers were included for statistical analysis of the data. Raw data were 
analyzed by unpaired t-test (comparison of two samples) or one-way ANOVA (comparison 
of multiple samples) analysis with the Tukey pairwise comparison using Graphpad Prism 
5.04 software. Values are expressed as mean ± SE; n = 3. A P-value < 0.05 was considered a 
significant difference between treatments, while P < 0.1 was considered a trend towards a 
difference.
Results
Effect of DMBA on ovarian γH2AX in lean and obese mice
γH2AX protein was absent in lean control-treated ovaries but was evident (P < 0.05) in 
obese ovaries that had received sesame oil. γH2AX protein level was increased (P < 0.05) 
by DMBA exposure in both lean and obese mice compared to their respective control-
treated ovaries (Figure 1A). Relative to lean mice when compared to its respective control, 
the DMBA-induced increase in γH2AX protein was lower in ovaries from obese mice 
(Figure 1B).
Impact of DMBA exposure on ovarian Atm abundance in lean and obese mice
Basal Atm mRNA levels were lower (P < 0.05) in ovaries from obese relative to lean mice. 
In lean mice, ovarian Atm mRNA levels were decreased (P < 0.05) by DMBA exposure 
compared to control-treated animals. In contrast, in obese mice, DMBA exposure increased 
(P < 0.05) ovarian Atm mRNA levels relative to control-treated obese mice (Figure 2A). 
There was no difference in basal ovarian ATM protein levels between lean and obese mice. 
Nor in the ATM protein response to DMBA which was elevated in both the lean and obese 
females (Figure 2B, C).
DMBA-induction of ovarian Xrcc6 mRNA and protein in lean and obese mice
Basal levels of Xrcc6 mRNA were lower (P < 0.05) in obese compared to lean mouse 
ovaries. In lean mice, levels of Xrcc6 mRNA were increased by DMBA exposure while, in 
contrast, DMBA exposure did not impact Xrcc6 in obese ovaries (Figure 3A). There was no 
impact of obesity on ovarian XRCC6 protein. In both lean and obese mice, relative to 
control-treated animals, levels of ovarian XRCC6 protein were increased (P < 0.05) by 
DMBA exposure. Interestingly, relative to lean DMBA-treated ovaries, DMBA-induced 
XRCC6 protein expression was lower (P < 0.05) in obese ovaries (Figure 3B, C).
Response of ovarian Prkdc mRNA and protein to DMBA exposure in lean and obese mice
Basal levels of Prkdc mRNA were lower (P < 0.05) in obese compared to lean ovaries. In 
lean mice, levels of Prkdc mRNA were decreased (P < 0.05) by DMBA exposure compared 
to control-treated ovaries. In contrast, DMBA exposure increased (P < 0.05) Prkdc mRNA 
level in ovaries from obese mice, compared to obese control-treated animals (Figure 4A). 
Basal PRKDC protein levels were lower (P < 0.05) in obese relative to lean ovaries. In lean 
mice, relative to control-treated animals, ovarian PRKDC protein was increased (P < 0.05) 
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by DMBA exposure (Figure 4B, C), but this response was absent in the obese female 
ovaries.
Impact of DMBA exposure on ovarian Brca1 mRNA and protein in lean and obese mice
Lower (P < 0.05) levels of basal Brca1 mRNA were observed in obese ovaries relative to 
lean ovaries. In both lean and obese mice, levels of Brca1 mRNA were increased (P < 0.05) 
by DMBA exposure compared to their respective control treatment, however, obesity 
resulted in a blunted DMBA-induced Brca1 mRNA increase (Figure 5A). Basal BRCA1 
protein levels were lower (P < 0.05) in obese relative to lean ovaries. In obese mice, relative 
to control-treated animals, levels of ovarian BRCA1 protein were increased (P < 0.05) by 
DMBA exposure while no BRCA1 induction was observed in lean mice (Figure 5B, C).
Ovarian DMBA-induced Rad51 mRNA and protein in lean and obese mice
No difference in basal Rad51 mRNA abundance between lean and obese ovarian tissue was 
observed (Figure 6A). In lean mice, levels of Rad51 mRNA was increased by DMBA 
exposure compared to control treatments, but this response was absent in obese ovaries 
(Figure 6A). There was no difference in basal RAD51 protein levels between lean and obese 
ovaries. In both lean and obese mice, RAD51 protein levels were increased (P < 0.05) by 
DMBA exposure compared to control treatments. Interestingly, the increase in RAD51 
protein level after DMBA exposure was lower (P < 0.05) in the obese relative to lean 
ovaries (Figure 6B, C).
DMBA-induction of ovarian Parp1 mRNA and protein in lean and obese mice
Higher basal levels of Parp1 mRNA were noted in obese compared to lean ovaries. In lean 
and obese mice, levels of Parp1 mRNA were increased (P < 0.05) by DMBA exposure 
compared to control treatments (Figure 7A). Basal PARP1 protein levels were higher in 
obese relative to lean ovaries. DMBA increased (P < 0.05) PARP1 protein in both lean and 
obese mice (Figure 7B, C).
Discussion
Obesity is a detrimental physiological state for oocyte quality and fertility (Wittemer et al., 
2000; Brewer and Balen, 2010). Maternal obesity also increases the risk of offspring birth 
defects (Watkins et al., 2003). Additionally, obesity alters the ovarian response to chemical 
insult, as evidenced by the results observed with DMBA, a known ovarian toxicant (Nteeba 
et al., 2014). DMBA depleted healthy follicles of all types in both lean and obese treated 
females compared to sesame-treated females (Nteeba et al., 2014). No difference in DMBA-
induced follicle depletion was observed between the lean and obese females likely due to the 
extensive DMBA damage that occurred in both, however ovarian weight was lower in the 
obese DMBA relative to the lean DMBA treated mice (Nteeba et al., 2014). These results 
indicate greater levels of DMBA-induced ovotoxicity in obese relative to lean mice, 
potentially through induction of DNA damage.
One mechanism to justify the potential for increased ovarian DNA damage caused by 
DMBA in obese mice is increased bioactivation of DMBA by the increased concentration of 
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ovarian mEH observed in obese mice (Nteeba et al., 2014). This increased mEH would 
generate more of the reactive diepoxide metabolite responsible for ovarian DNA damage 
(Miyata et al., 1999). Thus, ovarian DNA damage was assessed in ovaries of control and 
DMBA treated mice by monitoring molecular events involved in the DDR in response to 
formation of DSBs.
The action of ATM, which is recruited upon DSB formation to phosphorylate downstream 
cellular effector molecules results in either cell cycle arrest to accomodate DNA repair 
(Canmanet al., 1998; Lee and Paull, 2007) or apoptosis (Stankovic et al., 2002) (Waster and 
Ollinger, 2009). DMBA exposure decreased Atm mRNA level in lean ovaries while the 
opposite was the case in obese ovaries. Despite this, increased ATM protein was observed in 
both lean and obese ovaries upon DMBA exposure indicating that ovarian DNA damage is 
imparted by DMBA exposure. Activation of ATM, associated with apoptotic oocyte death, 
has been previously observed during doxorubicin exposure in embryonic stem cells 
(Soleimani et al., 2011). While it is difficult to conclude whether our conflicting effects of 
DMBA exposure in lean and obese ovaries on Atm mRNA levels indicate different 
mechanisms of regulation during obesity, it is clear that DMBA exposure increased ovarian 
ATM protein regardless of metabolic status, supporting that DMBA induces ovarian DNA 
damage in an in vivo model, consistant with our previous data in cultured neonatal rat 
ovaries (Ganesan et al., 2013).
When a DSB occurs, ATM phosphorylates H2AX (γH2AX), a sensitive marker of DSBs 
(Bouquet et al., 2006; Mah et al., 2010). We demonstrate increased γH2AX protein due to 
DMBA exposure regardless of the presence of obesity. These data are also in agreement 
with our previous study that found activated γH2AX protein in neonatal rat ovaries that had 
been exposure to DMBA (Ganesan et al., 2013). Interestingly, low levels of γH2AX protein 
were observed during obesity, independent of DMBA exposure, which may indicate that 
low level DNA damage is present in ovarian tissue of obese females. DNA damage in 
peripheral lymphocytes of obese and overweight italian children has been demonstrated 
(Jungheim et al., 2010), thus our data are in agreement with these studies. Taken together, 
these data further support that DMBA exposure induces ovarian DNA damage, and that the 
ovary is responsive to such an insult.
γH2AX recruits XRCC6 and PRKDC to repair DNA by the NHEJ pathway (Summers et al., 
2011). Xrcc6 mRNA was increased by DMBA exposure in lean ovaries but no change was 
observed with obesity, though a lower basal level was present. In contrast to mRNA data, 
XRCC6 protein was increased by DMBA in both lean and obese ovaries but this increase 
appeared to be blunted due to obesity. This lowered response could be due to basal DNA 
damage that is seemingly present in ovarian tissue during obesity as suggested by the 
observed γH2AX. Defective DNA repair and chromosomal instability due to decreased 
XRCC6 have been reported in embryonic cells (Gu et al., 1997). In addition, suppressed 
XRCC6 leads to DNA damage and reactive oxygen species-induced endoplasmic reticulum 
stress in Toll like receptor (TLR) 4 mutant liver cells, ultimately leading to induction of the 
ATM-PRKDC protein complex as well as induction of PARP1, resulting in apoptosis of 
precancerous hepatocytes (Wang et al., 2013). Prkdc mRNA expression was decreased by 
DMBA exposure in lean but increased in obese ovaries. In contrast, despite their being 
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reduced basal levels of PRKDC protein in obese relative to lean mice, PRKDC protein 
induction by DMBA exposure was observed in both lean and obese mice. Inhibition of 
PRKDC reduces γH2AX and the HR repair mechanism in a medaka embryonic cell line 
(Urushihara et al., 2012). Thus, our data suggest that increased PRKDC by DMBA exposure 
might play a pro-apoptotic role in ovarian tissue.
PARP1 is involved in DNA damage-induced cell apoptosis (D'Amours et al., 1999) and 
DMBA has been shown to increase PARP1 expression prior to follicle loss in neonatal rat 
ovaries (Ganesan et al., 2013). DMBA increased both Parp1 mRNA and protein in lean and 
obese ovaries, with ovaries from obese mice having higher basal levels of Parp1. Elevated 
Parp1 could play a role in DMBA-induced ovotoxicity, since PARP1 inhibition previously 
protected against cisplastin-induced renal damage and inflammation (Kim et al., 2012). 
Interestingly, the mitochondrial apoptotic pathway mediated by caspase 9 is constitutively 
activated in oocytes and contibutes to the elimination of oocytes with meiotic errors through 
the cleavage and activation of PARP1 (Ene et al., 2013). Thus, increased PARP1 observed 
in our study could mediate increased DMBA-induced ovotoxicity.
DMBA has been shown to induce ROS generation and DNA damage in Brca1 knock down 
MCF10A cells (Kang et al., 2013). In agreement with our previpous study demonstrating 
increased Brca1 in neonatal rat ovaries exposure to DMBA (Ganesan et al., 2013), we found 
increased DMBA-induced Brca1 mRNA in ovaries of lean mice but this response was partly 
attentuated in ovaries from obese mice. In contrast, BRCA1 protein was increased in ovaries 
from obese but not lean ovaries due to DMBA exposure. Interestingly, and in contrast to the 
observed increased γH2AX, we noted that basal Brca1 mRNA and protein abundance was 
lower due to obesity. Reduced Brca1 is associated with an increased risk of hereditary breast 
and ovarian cancer (Robson et al., 1998; Kauff et al., 2002). BRCA1 controls the mitotic 
checkpoint complex, and loss of this control can lead to mitotic errors contributing to 
neoplasia in ovarian cystadenoma cells (Yu et al., 2012). Further, women with Brca1 
mutations can experience earlier ovarian senescence and develop ovarian cancer at younger 
ages (Rzepka-Górska et al., 2006). Impairment of BRCA1-related DNA DSB repair has 
been associated with accelerated loss of the ovarian follicular reserve and with accumulation 
of DSB in human oocytes, suggesting that DNA DSB repair efficiency is an important 
determinant of oocyte aging in women (Titus et al., 2013). Interestingly, RAD51 interacts 
with BRCA1 during DDR and DMBA exposure increased RAD51 protein abundance in 
both prostate tissue (Xu et al., 2002) and in cultured neonatal rat ovaries (Ganesan et al., 
2013). In this study, DMBA exposure increased Rad51 mRNA levels in lean but not obese 
mice. Furthermore, ovarian RAD51 protein was upregulated by DMBA in the lean females 
but a reduced response was observed in ovaries from obese females. These impacts of 
obesity on the DMBA-induced BRCA1 and RAD51 proteins could contribute to negative 
impacts on female reproduction.
In summary, our results support that DMBA exposure induces DSB formation in the ovary 
and the DDR is activated in ovarian tissue of exposed mice. We provide novel data that the 
ovaries from obese female mice were observed to have a low level of γH2AX protein 
therein, indicating that DNA damage, outside of ovotoxicant exposure, may be present. 
Also, levels of some ovarian DDR proteins (XRCC6, BRCA1, PRKDC and RAD51) were 
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blunted due to obesity, suggesting perhaps a reduced ability to respond to chemical-induced 
DNA damage. Interestingly, we found a disconnect between mRNA and protein levels in 
some genes (Atm and Prkdc), perhaps indicating that a delay in transcript processing occurs 
in ovaries from obese mice, or that other regulators of gene expression are affected, 
potentially including microRNA as was previously found in a high fat feeding-induced 
obesity mouse model (Nteeba et al., 2013). These findings underscoring the importance of 
investigating translational as well as transcriptional effects of obesity. We found that 
immunolocalization of the proteins examined correlated well with the Western blotting data 
(supplemental Figure 1) and future studies are required to address both post-translational 
modifications in the proteins described herein and to quantifiy the changes in ovarian cells 
in which these modifications occur. It is important to note that this study represents a single 
snapshot in time of the DMBA-induced ovarian DDR. Taken together, a higher sensitivity to 
and suceptibility for DMBA-induced ovotoxicity effects in obese females is supported. As 
smokers have an increased exposure to DMBA, it will be important to determine if obese 
smokers show evidence of impaired ovarian function that is greater than that of non-obese 
smokers.
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Abbreviations
DMBA 7,12-dimethylbenz[a]anthracene
DDR DNA damage response
DSBs Double-strand breaks
NHEJ Non-Homologous End Joining
HR Homologous Recombination
TLR Toll like receptor
Cyp Cytochromes p450
IGF Insulin growth factor
PI3K Phosphatidylinositol-3 kinase
Akt Protein kinase B
ATM Ataxia telangiectasia mutated
XRCC6 X-ray repair complementing defective repair in chinese hamster cells 6
BRCA1 Breast cancer type 1
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RAD 51 Rad 51 homolog
PARP1 Poly [ADP-ribose] polymerase 1
PRKDC Protein kinase
DNA-activated catalytic polypeptide
γH2AX Phosphorylated histone H2AX
mEH microsomal Epoxide Hydrolase
TEMED N′N′N′N′-Tetramethylethylenediamine
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Highlights
DMBA induces markers of ovarian DNA damage
Obesity induces low level ovarian DNA damage
DMBA-induced DNA repair response is altered by obesity
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Figure 1. Effect of DMBA on ovarian H2AX phosphorylation in lean and obese mice
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; ip) for 14 days, 
followed by (A) Western blotting to detect γH2AX. Protein abundance was quantified using 
ImageJ software. Values are expressed as raw data mean ± SE; n=3. Different letters 
indicate P < 0.05.
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Figure 2. Impact of DMBA exposure on ovarian Atm abundance in lean and obese mice
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; ip) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Atm (A) mRNA or (B, C) protein abundance. (A) Atm was normalized to Gapdh for 
quantification, and values are reported as fold-change (n = 3) relative to lean CT ovaries (set 
at 1). (B) Protein abundance was quantified using ImageJ software; Lean control = LC; Lean 
DMBA = LD; Obese Control = OC, Obese DMBA = OD. Values are expressed as raw data 
mean ± SE; n=3. Different letters indicate P < 0.05.
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Figure 3. DMBA-induction of ovarian Xrcc6 mRNA and protein in lean and obese mice
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; ip) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Xrcc6 (A) mRNA or (B, C) protein abundance. (A) Xrcc6 was normalized to 
Gapdh for quantification, and values are reported as fold-change (n = 3) relative to lean CT 
ovaries (set at 1). (B) Protein abundance was quantified using ImageJ software; Lean control 
= LC; Lean DMBA = LD; Obese Control = OC, Obese DMBA = OD. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05.
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Figure 4. Response of ovarian Prkdc mRNA and protein to DMBA exposure in lean and obese 
mice
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; ip) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Prkdc (A) mRNA or (B, C) protein abundance. (A) Prkdc was normalized to 
Gapdh for quantification, and values are reported as fold-change (n = 3) relative to lean CT 
ovaries (set at 1). (B) Protein abundance was quantified using ImageJ software; Lean control 
= LC; Lean DMBA = LD; Obese Control = OC, Obese DMBA = OD. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05.
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Figure 5. Impact of DMBA exposure on ovarian Brca1 mRNA and protein in lean and obese 
mice
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; ip) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Brca1 (A) mRNA or (B, C) protein abundance. (A) Brca1 was normalized to 
Gapdh for quantification, and values are reported as fold-change (n = 3) relative to lean CT 
ovaries (set at 1). (B) Protein abundance was quantified using ImageJ software; Lean control 
= LC; Lean DMBA = LD; Obese Control = OC, Obese DMBA = OD. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05.
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Figure 6. Ovarian DMBA-induced Rad51 mRNA and protein in lean and obese mice
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; ip) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Rad51 (A) mRNA or (B, C) protein abundance. (A) Rad51 was normalized to 
Gapdh for quantification, and values are reported as fold-change (n = 3) relative to lean CT 
ovaries (set at 1). (B) Protein abundance was quantified using ImageJ software; Lean control 
= LC; Lean DMBA = LD; Obese Control = OC, Obese DMBA = OD. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05.
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Figure 7. DMBA-induction of ovarian Parp1 mRNA and protein in lean and obese mice
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; ip) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Parp1 (A) mRNA or (B, C) protein abundance. (A) Parp1 was normalized to 
Gapdh for quantification, and values are reported as fold-change (n = 3) relative to lean CT 
ovaries (set at 1). (B) Protein abundance was quantified using ImageJ software; Lean control 
= LC; Lean DMBA = LD; Obese Control = OC, Obese DMBA = OD. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05.
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Table 1
Gene Forward primer Reverse primer
Atm TCAGCAGCACCTCTGATTCTT AGACAGACATGCTGCCTCCT
Brcal CCCTCTTAGTCTGCTGAGCT CCTTTGGGTGGCTGTACTGA
Parpl AAGTGCCAGTGTCAAGGAGA ACAGGGAGCAAAAGGGAAGA
Prkdc GCCACAGACCCCAATATCCT TATCTGACCATCTCGCCAGC
Rad51 ATCCCTGCATGCTTGTTCTC CTGCAGCTGACCATAACGAA
Xrcc6 GATCTGACACTGCCCAAGGT TGCTTCTTCGGTCCACTCTT
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